1-2 of 2
Zhiwei Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and Dasatinib

Li Weiming, Yanli Zhang, Zhiwei Wu, Qin Wen, Qing Leng, Shuting Wu, Xiaodong Wang, Shiming Chen, Guolin Yuan, Sixuan Qian, Suning Chen, Daozi Jiang, Lianjun Diao, Zhenfang Xi, Hui Wu, Hui Sun, Lijie Yang, Hongjuan Wang, Xuefang Zhang, Yanli Xu, Xielan Zhao, Na Xu, Li Meng, Zunmin Zhu, Youfang Zhao, Meifang Su, Zhuangzhi Yang, Chuancai Liu, Danlei Han, Yu Hu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3171.
https://doi.org/10.1182/blood-2023-179142
Published: 2023
Journal Articles

The Comparison of Dasatinib 70 Mg/Day to 100 Mg/Day in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Multicenter, Prospective, Randomized Controlled Study

Dan Yu, Zhuangzhi Yang, Hui Cheng, Rui Jiang, Jingming Guo, Chucheng Wan, Jun Qin, Youshan Zhang, Guolin Yuan, Daozi Jiang, Chun Zhang, Fang Liu, Min Zhang, Shiming Chen, Caixia Liang, Jing Zou, Zhiwei Wu, Xiuping Zou, Danlei Han, Xu Chen, Li Wang, Tingting Lv, Xiaolong Tian, Yanping Xie, Hongyu An, Li Yan, Yicheng Zhang, Weiming Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 3615.
https://doi.org/10.1182/blood-2021-148349
Published: 2021